8Congenital & childhood hearing loss

FWhy congenital loss matters most

Hearing loss at any age is a burden, but loss that is present from birth or arrives before a child has learned to speak is in a category of its own. The lesson of Chapter 3 was that the brain has a sensitive period during which it must receive sound to build the pathways for language. A child born deaf is on a clock from the first day; every month of silence during that window is harder to recover later. This is why congenital and early-childhood loss, though a small fraction of the total headcount, carries an outsized share of the lifelong disability — and why it is the heart of paediatric cochlear implantation.

FHow common is it?

Permanent congenital hearing loss affects roughly one to two per thousand live births in well-studied populations — a birth prevalence high enough to make it one of the commonest conditions screened for at birth. In settings with more congenital infection, consanguinity, and perinatal risk, the figure runs higher. This single statistic is the entire justification for universal newborn hearing screening, the subject of the next module.

FTThe genetic / acquired split

As a rule of thumb, about half of congenital hearing loss is genetic and half acquired, though the balance tips toward acquired causes wherever infection and perinatal risk are high — as in much of India. The genetic half is mostly non-syndromic and recessive (Module 7); the acquired half is dominated by causes that good public health can prevent. Knowing the likely half matters clinically: the genetic, non-syndromic causes typically spare the auditory nerve and predict good implant outcomes, while some acquired causes (meningitis especially) threaten the cochlea and nerve themselves.

FTCongenital infection

Two infections deserve particular mention. Congenital cytomegalovirus (CMV) is the leading non-genetic cause of childhood sensorineural hearing loss worldwide; the loss may be present at birth or appear and progress over the first years, which means a child can pass a newborn screen and still go on to lose hearing. Congenital rubella— now vaccine-preventable but historically a major cause in India — produces deafness as part of a wider syndrome. Both make the case that prevention (vaccination, maternal health) and ongoing surveillance, not a single birth test, are what protect a child's hearing.

CPerinatal risk factors

Beyond infection, the events around birth carry their own risk: prematurity and low birth weight, birth asphyxia / hypoxia, severe neonatal jaundice (hyperbilirubinaemia, which is toxic to the auditory pathway), neonatal sepsis and meningitis, and ototoxic drug exposurein neonatal intensive care. These define the “high-risk register” that targeted screening programmes prioritise, and they are commoner wherever maternal and newborn care is stretched — adding to India's acquired share.[2012]

FCRacing the developmental clock

Whatever the cause, the consequence converges on a single principle: time is the enemy. A congenitally deaf child whose loss is detected and treated within the first months can develop spoken language on a near-normal trajectory; the same child detected at three or four has lost ground that may never be fully regained (Chapter 3). The entire architecture of modern paediatric hearing care — newborn screening, rapid diagnosis, early implantation — exists to shorten the interval between a child's deafness and the day sound first reaches the brain.

That architecture begins with finding the affected children in the first place — which is the task of newborn and infant hearing screening (Module 9).